134 related articles for article (PubMed ID: 22185941)
21. Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi.
Pinilla YT; C P Lopes S; S Sampaio V; Andrade FS; Melo GC; Orfanó AS; Secundino NFC; Guerra MGVB; Lacerda MVG; Kobylinski KC; Escobedo-Vargas KS; López-Sifuentes VM; Stoops CA; Baldeviano GC; Tarning J; Vasquez GM; Pimenta PFP; Monteiro WM
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006221. PubMed ID: 29444080
[TBL] [Abstract][Full Text] [Related]
22. Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum.
Wampfler R; Hofmann NE; Karl S; Betuela I; Kinboro B; Lorry L; Silkey M; Robinson LJ; Mueller I; Felger I
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005753. PubMed ID: 28732068
[TBL] [Abstract][Full Text] [Related]
23. Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure.
Warrasak S; Euswas A; Fukuda MM; Ittiverakul M; Miller RS; Krudsood S; Ohrt C
Int Ophthalmol; 2019 Aug; 39(8):1767-1782. PubMed ID: 30269312
[TBL] [Abstract][Full Text] [Related]
24. Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence.
Silvino ACR; Kano FS; Costa MA; Fontes CJF; Soares IS; de Brito CFA; Carvalho LH; Sousa TN
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122891
[No Abstract] [Full Text] [Related]
25. [Does the brief treatment with antimalarials favorably influence drug resistance and recurrences?].
Kroeger A
Rev Panam Salud Publica; 2001 Mar; 9(3):202-4. PubMed ID: 11349355
[No Abstract] [Full Text] [Related]
26. Experimental studies on combinations of pyronaridine/primaquine versus chloroquine/primaquine.
Shao BR; Zhan CQ; Chen KY; Ye XY; Lin BY; Ha SH; Zhang JX
Chin Med J (Engl); 1990 Dec; 103(12):1024-6. PubMed ID: 2127247
[TBL] [Abstract][Full Text] [Related]
27. Primaquine resistance in Plasmodium vivax.
Collins WE; Jeffery GM
Am J Trop Med Hyg; 1996 Sep; 55(3):243-9. PubMed ID: 8842108
[TBL] [Abstract][Full Text] [Related]
28. Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence.
Val F; Costa FT; King L; Brito-Sousa JD; Bassat Q; Monteiro WM; Siqueira AM; Luzzatto L; Lacerda MV
Future Microbiol; 2019 Oct; 14():1261-1279. PubMed ID: 31596137
[TBL] [Abstract][Full Text] [Related]
29. Can primaquine therapy for vivax malaria be improved?
Baird JK; Rieckmann KH
Trends Parasitol; 2003 Mar; 19(3):115-20. PubMed ID: 12643993
[TBL] [Abstract][Full Text] [Related]
30. Primaquine-thiazolidinones block malaria transmission and development of the liver exoerythrocytic forms.
Aguiar AC; Figueiredo FJ; Neuenfeldt PD; Katsuragawa TH; Drawanz BB; Cunico W; Sinnis P; Zavala F; Krettli AU
Malar J; 2017 Mar; 16(1):110. PubMed ID: 28279180
[TBL] [Abstract][Full Text] [Related]
31. Enantioselective pharmacokinetics of primaquine in healthy human volunteers.
Tekwani BL; Avula B; Sahu R; Chaurasiya ND; Khan SI; Jain S; Fasinu PS; Herath HM; Stanford D; Nanayakkara NP; McChesney JD; Yates TW; ElSohly MA; Khan IA; Walker LA
Drug Metab Dispos; 2015 Apr; 43(4):571-7. PubMed ID: 25637634
[TBL] [Abstract][Full Text] [Related]
32. Validation of a method for the simultaneous quantification of chloroquine, desethylchloroquine and primaquine in plasma by HPLC-DAD.
Zuluaga-Idárraga L; Yepes-Jiménez N; López-Córdoba C; Blair-Trujillo S
J Pharm Biomed Anal; 2014 Jul; 95():200-6. PubMed ID: 24682018
[TBL] [Abstract][Full Text] [Related]
33. In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.
Ganguly S; Saha P; Guha SK; Das S; Bera DK; Biswas A; Kundu PK; Saha B; Ray K; Maji AK
Antimicrob Agents Chemother; 2013 Mar; 57(3):1246-51. PubMed ID: 23262997
[TBL] [Abstract][Full Text] [Related]
34. A clinical view of the biology of Plasmodia.
Altstatt LB
Ann Intern Med; 1969 Jan; 70(1):130-4. PubMed ID: 4884380
[No Abstract] [Full Text] [Related]
35. Primaquine for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
[TBL] [Abstract][Full Text] [Related]
36. Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.
St Jean PL; Xue Z; Carter N; Koh GC; Duparc S; Taylor M; Beaumont C; Llanos-Cuentas A; Rueangweerayut R; Krudsood S; Green JA; Rubio JP
Malar J; 2016 Feb; 15():97. PubMed ID: 26888075
[TBL] [Abstract][Full Text] [Related]
37. Letter: Transfusion-induced malaria.
Am J Dis Child; 1973 Dec; 126(6):861. PubMed ID: 4586254
[No Abstract] [Full Text] [Related]
38. Biological resistance of hydroxychloroquine for Plasmodium vivax malaria in the Republic of Korea.
Lee SW; Lee M; Lee DD; Kim C; Kim YJ; Kim JY; Green MD; Klein TA; Kim HC; Nettey H; Ko DH; Kim H; Park I
Am J Trop Med Hyg; 2009 Oct; 81(4):600-4. PubMed ID: 19815873
[TBL] [Abstract][Full Text] [Related]
39. [Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
Vásquez AM; Sanín F; Alvarez LG; Tobón A; Ríos A; Blair S
Biomedica; 2009 Jun; 29(2):307-19. PubMed ID: 20128355
[TBL] [Abstract][Full Text] [Related]
40. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
